 - Anticoagulants other than aspirin and anti-platelet agents within 7 days prior to randomization. The concurrent use of low molecular weight heparin or heparanoids or low dose warfarin i.e, 1 mg daily for prophylaxis against thrombosis is acceptable while on study 